Home/Filings/4/0001181431-07-038741
4//SEC Filing

TRAINOR III EUGENE A 4

Accession 0001181431-07-038741

CIK 0001178879other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 8:28 PM ET

Size

28.9 KB

Accession

0001181431-07-038741

Insider Transaction Report

Form 4
Period: 2007-06-05
DRANT RYAN D
10% Owner
Transactions
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
Transactions
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
Transactions
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
BARRETT M JAMES
Director10% Owner
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
Transactions
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
Transactions
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
Transactions
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
Transactions
  • Conversion

    Series C Convertible Preferred Stock

    2007-06-051,016,2200 total
    Common Stock (1,016,220 underlying)
  • Exercise of In-Money

    Series B Convertible Preferred Stock Warrant (Right to Buy)

    2007-06-0515,0770 total
    Exercise: $6.38From: 2004-05-04Exp: 2014-05-04Common Stock (15,077 underlying)
  • Conversion

    Common Stock

    2007-06-05+3,650,4883,650,488 total
  • Sale

    Common Stock

    2007-06-05$15.00/sh6,408$96,1203,659,157 total
  • Exercise of In-Money

    Common Stock

    2007-06-05$6.38/sh+15,077$96,1163,665,565 total
  • Conversion

    Series B Convertible Preferred Stock

    2007-06-05990,7960 total
    Common Stock (990,796 underlying)
  • Conversion

    Series D Convertible Preferred Stock

    2007-06-051,643,4720 total
    Common Stock (1,643,472 underlying)
Footnotes (4)
  • [F1]Each of the Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into the Issuer's common stock on a one for one basis upon the closing of the Issuer's initial public offering on June 5, 2007.
  • [F2]The securities are directly held by New Enterprise Associates 11, Limited Partnership ("NEA 11") and indirectly held by NEA PArtners 11, Limited Partnership ("NEA Partners 11"), the sole general partners of NEA 11, NEA 11 GP, LLC ("NEA GP"), the sole general partner of NEA Partners 11, and the individual managers of NEA GP (NEA Partners 11, NEA GP and the individual managers of NEA GP together, the "Indirect Reporting Person"). The individual managers of NEA GP are M. James Barrett, Forest Baskett, Ryan D. Drant, Krishna "Kittu" Kolluri, C. Richard Kramlich, Charles M. Linehan, Charles W. Newhall III, Mark W. Perry, Scott D. Sandell and Eugene A. Trainor III. Each Indirect Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 11 shares in which such Indirect Reporting Person has no actual pecuniary interest therein.
  • [F3]Net exercise of warrant held by the Reporting Person for an aggregate acquisition of 8,669 shares of Common Stock.
  • [F4]The warrant was net exercised upon the closing of the Issuer's initial public offering.

Documents

1 file

Issuer

AMICUS THERAPEUTICS INC

CIK 0001178879

Entity typeother

Related Parties

1
  • filerCIK 0001172932

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 8:28 PM ET
Size
28.9 KB